Patent ID: 6399583
Filing Date: 2002-06-04
Classification: A61P,C07H,C12P

Abstract:
Anthracycline compounds useful in cancer therapy, having the formula II, whereinR1 is CH2CH3, R2 is COOCH3, R3 is OH and R4 is Rhn-dF-dF, or R1 is CH3, R2 is OH, R3 is OH and R4 is Rhn-dF, or R1 is CH2CH3, R2 is H, R3 is H and R4 is Rhn-dF-dF, or R1 is CH3, R2 is OH, R3 is H and R4 is Rhn-dF, or R1 is CH2CH3, R2 is OH, R3 is H and R4 is Rhn-dF, or R1 is CH3, R2 is OH, R3 is OH and R4 is dF-dF, or R1 is CH2CH3, R2 is OH, R3 is H and R4 is Rhn-dF-dF, or R1 is CH3, R2 is OH, R3 is H and R4 is Rhn, or R1 is CH3, R2 is COOCH3, R3 is OH and R4 is dF-dF, or R1 is CH2CH3, R2 is OH, R3 is H and R4 is dF-dF-dF, or R1 is CH3, R2 is COOCH3, R3 is H and R4 is dF-dF-dF, or R1 is CH2CH3, R2 is OH, R3 is OH and R4 is Rhn-dF-dF, and wherein Rhn is rhodosamine and dF is deoxyfulcose.